BMRN - BioMarin Pharmaceutical Q2 2023 Earnings Preview

2023-07-30 17:35:00 ET

• BioMarin Pharmaceutical ( NASDAQ: BMRN ) is scheduled to announce Q2 earnings results on Monday, July 31st, after market close.
• The consensus EPS Estimate is $0.47 (+213.3% Y/Y) and the consensus Revenue Estimate is $595.24M (+11.5% Y/Y).
• Over the last 1 year, BMRN has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
• Over the last 3 months, EPS estimates have seen 4 upward revisions and 6 downward. Revenue estimates have seen 7 upward revisions and 8 downward.

For further details see: